
4-(2-Aminoethyl)amino-7-chloroquinoline
CAS No. 5407-57-8
4-(2-Aminoethyl)amino-7-chloroquinoline( —— )
Catalog No. M37048 CAS No. 5407-57-8
4-(2-Aminoethyl)amino-7-chloroquinoline (N1-(7-Chloroquinolin-4-yl)ethane-1,2-diamine) has potential anthelmintic and antitumor activity for the study of malaria.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
50MG | 30 | In Stock |
![]() ![]() |
100MG | 41 | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product Name4-(2-Aminoethyl)amino-7-chloroquinoline
-
NoteResearch use only, not for human use.
-
Brief Description4-(2-Aminoethyl)amino-7-chloroquinoline (N1-(7-Chloroquinolin-4-yl)ethane-1,2-diamine) has potential anthelmintic and antitumor activity for the study of malaria.
-
Description4-(2-Aminoethyl)amino-7-chloroquinoline (N1-(7-Chloroquinolin-4-yl)ethane-1,2-diamine) has potential anthelmintic and antitumor activity for the study of malaria.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetParasite
-
RecptorParasite
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number5407-57-8
-
Formula Weight221.69
-
Molecular FormulaC11H12ClN3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESNCCNc1ccnc2cc(Cl)ccc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog



related products
-
FR900098 sodium salt
FR 900098 is a derivative of fosmidomycin that inhibits DOXP reductoisomerase, demonstrates antimalarial activity with IC50 of 170, 170, and 90 nM for HB3, A2, and Dd2 P. falciparum strains, respectively.
-
5-(3-bromo-4,5-dihyd...
Antileishmanial agent-2 is a 3-Br-isoxazoline-Based Inhibitors against Plasmodium falciparum (D10 and W2 strains) and Leishmania spp. (L. infantum and L. tropica) Promastigotes with IC50s of 0.035, 0.058, 3.5 and 7.5 μM.
-
N-(2-Hydroxypropyl)m...
N-(2-Hydroxypropyl)methacrylamide is used in the synthesis of copolymers for the targeted delivery of antileishmanial agents in Visceral leishmaniasis.